Lixin Wei Selected Research

Pharmaceutical Preparations

1/2021	Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL).
10/2019	A Novel Zebrafish Larvae Hypoxia/Reoxygenation Model for Assessing Myocardial Ischemia/Reperfusion Injury.
3/2019	HgS Inhibits Oxidative Stress Caused by Hypoxia through Regulation of 5-HT Metabolism Pathway.
8/2017	Characterization and cardioprotective activity of anthocyanins from Nitraria tangutorum Bobr. by-products.
10/2015	Controlled and Targeted Drug Delivery by a UV-responsive Liposome for Overcoming Chemo-resistance in Non-Hodgkin Lymphoma.
1/2013	Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lixin Wei Research Topics

Disease

52	Neoplasms (Cancer) 03/2022 - 06/2002
23	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2007
10	Carcinogenesis 12/2021 - 08/2005
7	Fibrosis (Cirrhosis) 10/2021 - 09/2008
6	Hypoxia (Hypoxemia) 10/2019 - 11/2009
5	Liver Neoplasms (Liver Cancer) 01/2021 - 06/2002
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2010
5	Inflammation (Inflammations) 08/2017 - 12/2014
5	Infections 05/2015 - 06/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 08/2017 - 12/2014
4	Adenocarcinoma 07/2017 - 01/2014
3	Chronic Renal Insufficiency 01/2021 - 11/2017
3	Starvation 01/2021 - 09/2013
3	Liver Diseases (Liver Disease) 01/2020 - 12/2016
3	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 08/2017 - 03/2015
3	Carcinoma (Carcinomatosis) 12/2014 - 04/2014
3	Stomach Neoplasms (Stomach Cancer) 09/2014 - 12/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 01/2011
2	Dehydration (Water Stress) 07/2021 - 04/2021
2	Membranous Glomerulonephritis (Membranous Nephropathy) 07/2020 - 03/2018
2	End Stage Liver Disease 01/2020 - 09/2014
2	Reperfusion Injury 10/2019 - 08/2017
2	Diarrhea 05/2019 - 04/2018
2	Cholangiocarcinoma 12/2017 - 11/2012
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2015 - 05/2015
2	Fatigue 10/2015 - 11/2013
2	Necrosis 06/2013 - 11/2011
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 12/2009 - 10/2009
1	Human Influenza (Influenza) 10/2022
1	Huntington Disease (Huntington's Disease) 03/2022
1	Hypotension (Low Blood Pressure) 01/2021

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
6	Messenger RNA (mRNA)IBA 11/2017 - 11/2007
6	Small Interfering RNA (siRNA)IBA 05/2015 - 11/2006
5	Biomarkers (Surrogate Marker)IBA 07/2020 - 01/2009
4	CytokinesIBA 10/2021 - 11/2011
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 03/2008
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2014 - 02/2007
4	Transcription Factors (Transcription Factor)IBA 10/2013 - 08/2005
4	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2008 - 11/2007
3	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 02/2022 - 01/2015
3	Biological ProductsIBA 01/2020 - 01/2013
3	Serotonin (5 Hydroxytryptamine)IBA 05/2019 - 04/2018
3	Chloroquine (Aralen)FDA LinkGeneric 01/2019 - 01/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 08/2011
3	ErbB Receptors (EGF Receptor)IBA 07/2017 - 01/2011
3	Epithelial Cell Adhesion MoleculeIBA 12/2014 - 12/2010
3	GlypicansIBA 04/2014 - 10/2009
2	CollagenIBA 03/2022 - 04/2011
2	EmulsionsIBA 07/2021 - 04/2021
2	MethyltransferasesIBA 01/2021 - 07/2018
2	Sirtuin 1IBA 01/2020 - 12/2014
2	LipidsIBA 01/2020 - 11/2013
2	OvalbuminIBA 05/2019 - 04/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2019 - 06/2013
2	zuotaiIBA 03/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 07/2018 - 01/2015
2	Decitabine FDA Link 07/2018 - 11/2007
2	Sucrose (Saccharose)IBA 01/2018 - 08/2017
2	Gemcitabine FDA Link 12/2017 - 01/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2017 - 09/2014
2	Liposomes (Liposome)IBA 08/2017 - 10/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 02/2016 - 11/2007
2	MucinsIBA 01/2016 - 08/2015
2	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2015 - 03/2015
2	Polysaccharides (Glycans)IBA 10/2015 - 11/2013
2	Monoclonal AntibodiesIBA 01/2015 - 11/2002
2	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 11/2013
2	ParaffinIBA 04/2014 - 01/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 08/2011
2	AntioxidantsIBA 11/2013 - 06/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2013 - 10/2008
2	Beclin-1IBA 11/2011 - 11/2009
2	DesminIBA 04/2011 - 05/2010
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2009 - 08/2005
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Hypoxia-Inducible Factor 1IBA 03/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	lenvatinibIBA 01/2022
1	3' Untranslated Regions (3' UTR)IBA 12/2021
1	Glutamine (L-Glutamine)FDA Link 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	HMGB1 Protein (HMG1)IBA 12/2021
1	Oncostatin MIBA 10/2021
1	DNA Repair EnzymesIBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Alkylating AgentsIBA 01/2021
1	Nifedipine (Adalat)FDA LinkGeneric 01/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Epirubicin (Ellence)FDA LinkGeneric 01/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021

Therapy/Procedure

15	Therapeutics 12/2021 - 06/2002
11	Drug Therapy (Chemotherapy) 01/2021 - 12/2008
3	Immunotherapy 12/2021 - 11/2002
2	Aftercare (After-Treatment) 03/2019 - 06/2002
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 12/2016